Dr. Kew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- Section Chief, Transplant Nephrology
Education & Training
- University of Alabama Medical CenterFellowship, Transplant Nephrology, 1996 - 1997
- University of ConnecticutFellowship, Nephrology, 1993 - 1995
- University of ConnecticutResidency, Internal Medicine, 1990 - 1993
- State University of New York Downstate Medical Center College of MedicineClass of 1990
Certifications & Licensure
- FL State Medical License 2022 - Present
- AL State Medical License 1996 - 2024
- CT State Medical License 1993 - 1997
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Live Kidney Donor Study Start of enrollment: 2007 Aug 01
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 8 citationsAvoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real life scenarioAudrey Ang, C. Schieve, S. Rose, Clifton E. Kew, M Roy First
Clinical Transplantation. 2021-01-01 - 15 citationsImpact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes.Michael E. Seifert, Gaurav Agarwal, Miriam Bernard, Ellen Kasik, S Sikandar Raza
Transplantation Direct. 2021-01-26 - 33 citationsPosttransplant Lymphoproliferative Disorder Localized Near The Allograft In Renal TransplantationClifton E. Kew, Robert Lopez-Ben, J. Kevin Smith, Michelle L. Robbin, William J. Cook
Transplantation. 2000-03-15
Journal Articles
- Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT TrialDaniel E Weiner, Meyeon Park, Alin A Joseph, Nitender Goyal, Chi-Yuan Hsu, Clifton E Kew, Todd E Pesavento, Andrew S Levey, American Journal of Kidney Diseases
Authored Content
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
Press Mentions
- Could Trump’s Kidney Disease Order Push Telehealth, mHealth Adoption?July 11th, 2019
Professional Memberships
- American Society of TransplantationFellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: